Capital International Sarl’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.54M | Buy |
6,288
+1,875
| +42% | +$437K | 0.03% | 205 |
|
|
2025
Q4 | $913K | Buy |
+4,413
| New | +$873K | 0.01% | 248 |
|
|
2025
Q2 | – | Sell |
-2,675
| Closed | -$444K | – | 294 |
|
|
2025
Q1 | $444K | Sell |
2,675
-8,805
| -77% | -$1.38M | 0.01% | 274 |
|
|
2024
Q4 | $1.66M | Sell |
11,480
-14
| -0.1% | -$2.17K | 0.04% | 201 |
|
|
2024
Q3 | $1.86M | Sell |
11,494
-1,840
| -14% | -$293K | 0.05% | 176 |
|
|
2024
Q2 | $1.95M | Sell |
13,334
-8,027
| -38% | -$1.19M | 0.06% | 173 |
|
|
2024
Q1 | $3.38M | Sell |
21,361
-631
| -3% | -$100K | 0.11% | 151 |
|
|
2023
Q4 | $3.45M | Sell |
21,992
-426
| -2% | -$65.3K | 0.13% | 150 |
|
|
2023
Q3 | $3.49M | Sell |
22,418
-8,470
| -27% | -$1.4M | 0.16% | 138 |
|
|
2023
Q2 | $5.11M | Buy |
+30,888
| New | +$4.99M | 0.23% | 116 |
|
|
2022
Q1 | – | Sell |
-18,120
| Closed | -$3.1M | – | 267 |
|
|
2021
Q4 | $3.1M | Hold |
18,120
| – | – | 0.15% | 154 |
|
|
2021
Q3 | $2.93M | Buy |
18,120
+24
| +0.1% | +$4.09K | 0.26% | 106 |
|
|
2021
Q2 | $2.98M | Sell |
18,096
-788
| -4% | -$130K | 0.26% | 107 |
|
|
2021
Q1 | $3.1M | Sell |
18,884
-1,102
| -6% | -$178K | 0.3% | 95 |
|
|
2020
Q4 | $3.15M | Sell |
19,986
-696
| -3% | -$103K | 0.33% | 94 |
|
|
2020
Q3 | $3.08M | Sell |
20,682
-740
| -3% | -$109K | 0.38% | 80 |
|
|
2020
Q2 | $3.01M | Buy |
21,422
+2,721
| +15% | +$397K | 0.4% | 72 |
|
|
2020
Q1 | $2.45M | Buy |
+18,701
| New | +$2.65M | 0.45% | 67 |
|
|
2019
Q1 | – | Sell |
-10,200
| Closed | -$1.32M | – | 142 |
|
|
2018
Q4 | $1.32M | Buy |
+10,200
| New | +$1.42M | 0.16% | 111 |
|
|
2018
Q3 | – | Sell |
-1,400
| Closed | -$170K | – | 131 |
|
|
2018
Q2 | $170K | Hold |
1,400
| – | – | 0.02% | 132 |
|
|
2018
Q1 | $179K | Hold |
1,400
| – | – | 0.02% | 134 |
|
|
2017
Q4 | $196K | Sell |
1,400
-40,750
| -97% | -$5.68M | 0.02% | 134 |
|
|
2017
Q3 | $5.48M | Sell |
42,150
-6,500
| -13% | -$862K | 0.46% | 70 |
|
|
2017
Q2 | $6.44M | Buy |
48,650
+3,850
| +9% | +$491K | 0.56% | 58 |
|
|
2017
Q1 | $5.58M | Buy |
44,800
+2,000
| +5% | +$239K | 0.48% | 67 |
|
|
2016
Q4 | $4.93M | Buy |
42,800
+3,300
| +8% | +$381K | 0.45% | 74 |
|
|
2016
Q3 | $4.67M | Hold |
39,500
| – | – | 0.39% | 77 |
|
|
2016
Q2 | $4.79M | Buy |
+39,500
| New | +$4.49M | 0.41% | 82 |
|
Other funds holding JNJ
VCM
VPM
Capital International Sarl's JNJ Position: Q1 2026 in Review
Capital International Sarl increased its Johnson & Johnson (JNJ) stake by 42% in Q1 2026, buying an estimated $437K and bringing the position to 6,288 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #205.
Capital International Sarl first reported a position in JNJ in Q2 2016 and has held it in 28 quarters since. The position peaked at $6.44M in Q2 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Capital International Sarl held 6,288 shares of Johnson & Johnson worth $1.54M as of Q1 2026.
- Capital International Sarl bought 1,875 Johnson & Johnson shares in Q1 2026, an estimated $437K.
- Johnson & Johnson made up 0.03% of Capital International Sarl's portfolio in Q1 2026, its #205 holding.
- Capital International Sarl first reported a position in Johnson & Johnson in Q2 2016 and has held it in 28 quarters since.
- Capital International Sarl's Johnson & Johnson position peaked at $6.44M in Q2 2017.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Capital International Sarl's 13F filing for Q1 2026, filed 13 May 2026.